SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: farkarooski who wrote (229)2/26/2003 12:36:22 PM
From: noel berge  Read Replies (1) of 250
 
Has anyone done any analysis of VXGN via each of it's potential markets and come up with it's tangible value?

I am well aware that it just tumbled and that there are many company, sector and even market happenings that COULD bring it down further.

however, I am interested in the tangible value, if someone has done the analysis, what the TV is for this company. If it is $35-40, as mentioned recently, is that based on data for '04, '05 or what?

Any feedback appreciated.

Noël
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News